NADAC acquisition cost data for CORTIFOAM 10% AEROSOL. This is a brand-name medication — generic alternatives may be available at lower prices.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 00037683015 | $26.45 | 2022-03-15 | Rx |
| 00037683015 | $26.45 | 2022-03-15 | Rx |
| 00037683015 | $26.45 | 2022-03-15 | Rx |
| 00037683015 | $26.45 | 2022-03-15 | Rx |
| 00037683015 | $26.45 | 2022-03-15 | Rx |
| 00037683015 | $26.45 | 2022-03-15 | Rx |
| 00037683015 | $26.45 | 2022-03-15 | Rx |
| 00037683015 | $26.45 | 2022-03-15 | Rx |
| 00037683015 | $26.45 | 2022-03-15 | Rx |
| 00037683015 | $26.45 | 2022-03-15 | Rx |
Generic: Hydrocortisone Acetate | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $7.8K | 17 | N/A | $27.43 |
| 2020 | $10.1K | 18 | 12 | $27.29 |
| 2021 | $258.1K | 467 | 281 | $26.80 |
| 2022 | $411.6K | 652 | 375 | $28.49 |
| 2023 | $527.7K | 799 | 430 | $28.65 |
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| New York | $72.1K | 96 | 51 |
| California | $46.6K | 75 | 43 |
| Pennsylvania | $31.5K | 55 | 37 |
| Florida | $29.1K | 32 | 17 |
| Texas | $26.1K | 52 | 32 |
| Massachusetts | $24.7K | 31 | 19 |
| Idaho | $23.4K | 15 | N/A |
| New Jersey | $21.6K | 39 | 17 |
| Missouri | $21.2K | 12 | N/A |
| Connecticut | $19.5K | 28 | 13 |
| Minnesota | $18.4K | 37 | N/A |
| Maryland | $16.2K | 32 | 17 |
| Louisiana | $15.3K | 22 | N/A |
| Illinois | $15.0K | 20 | 17 |
| New Hampshire | $12.1K | 14 | N/A |
| Colorado | $12.0K | 14 | N/A |
| North Carolina | $10.9K | 22 | 11 |
| Georgia | $10.4K | 16 | N/A |
| Virginia | $10.1K | 16 | N/A |
| Arizona | $9.4K | 17 | N/A |
| Michigan | $9.3K | 18 | 13 |
| Indiana | $6.6K | 15 | N/A |
| Ohio | $6.0K | 14 | N/A |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.